Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6153229rdf:typepubmed:Citationlld:pubmed
pubmed-article:6153229lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6153229lifeskim:mentionsumls-concept:C0220656lld:lifeskim
pubmed-article:6153229lifeskim:mentionsumls-concept:C0023561lld:lifeskim
pubmed-article:6153229lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:6153229pubmed:issue1lld:pubmed
pubmed-article:6153229pubmed:dateCreated1980-3-27lld:pubmed
pubmed-article:6153229pubmed:abstractTextLeVeen shunts were placed in ten patients bedridden with intractable malignant ascites in order to improve comfort and ambulation. The procedure was done with local anesthesia and mild sedation in all but one patient. Mild prolongations in clotting studies and hypokalemia were noted in several patients, but severe complications were few: a bleeding diathesis in a jaundiced patient, and venous disease in two. Six of the ten had excellent clinical response and were able to undergo therapy impossible in the presence of massive ascites. Two had moderate benefit but remained bedridden. Two patients gained no relief. Elevated bilirubin and inability to tolerate rapid increase in vascular volume and excrete the fluid load contraindicate the procedure, but the LeVeen shunt appears to be of significant clinical benefit in selected cases of malignant ascites.lld:pubmed
pubmed-article:6153229pubmed:languageenglld:pubmed
pubmed-article:6153229pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153229pubmed:citationSubsetIMlld:pubmed
pubmed-article:6153229pubmed:statusMEDLINElld:pubmed
pubmed-article:6153229pubmed:issn0022-4790lld:pubmed
pubmed-article:6153229pubmed:authorpubmed-author:MintonJ PJPlld:pubmed
pubmed-article:6153229pubmed:authorpubmed-author:FabianT CTClld:pubmed
pubmed-article:6153229pubmed:authorpubmed-author:KudskKKlld:pubmed
pubmed-article:6153229pubmed:issnTypePrintlld:pubmed
pubmed-article:6153229pubmed:volume13lld:pubmed
pubmed-article:6153229pubmed:ownerNLMlld:pubmed
pubmed-article:6153229pubmed:authorsCompleteYlld:pubmed
pubmed-article:6153229pubmed:pagination61-6lld:pubmed
pubmed-article:6153229pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:meshHeadingpubmed-meshheading:6153229-...lld:pubmed
pubmed-article:6153229pubmed:year1980lld:pubmed
pubmed-article:6153229pubmed:articleTitleLeVeen shunts in patients with intractable malignant ascites.lld:pubmed
pubmed-article:6153229pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153229lld:pubmed